Skip to content

Scientific publications

  • article Simard ML, Novak N, Drolet JP, Joly MC, Nolte H, Wuestenberg E, Gagnon R

    Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study

    Clin Exp Allergy 54 (2), 2024.

    DOI PUBMED
  • article Fitzpatrick T, Yamoah P, Lacuesta G, Sadarangani M, Cook V, Pourshahnazari P, Kalicinsky C, Upton JEM, Cameron SB, Zaborniak K, Kanani A, Lam G, Burton C, Constantinescu C, Pernica JM, Abdurrahman Z, Betschel S, Drolet JP, De Serres G, Quach C, Des Roches A, Chapdelaine H, Salvadori MI, Carignan A, McConnell A, Pham-Huy A, Buchan CA, Cowan J, Hildebrand K, Top KA and

    Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study

    Vaccine 42 (24), 2024.

    DOI PUBMED
  • article Brillant-Marquis F, Proulx É and Ratnarajah K, Lavoie A, Gauthier A, Gagnon R, Boursiquot JN, Verreault N, Marois L, Bédard MA, Boivin M, Bédard PM, Ouakki M, De Serres G, Drolet JP

    Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults

    J Allergy Clin Immunol Pract 12 (2), 2024.

    DOI PUBMED
  • article Picard M, Drolet JP, Masse MS, Filion CA, ALMuhizi F, Fein M, Copaescu A, Isabwe GAC, Blaquière M, Primeau MN

    Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series

    J Allergy Clin Immunol Pract 10 (2), 2022.

    DOI PUBMED
  • article Zafack JG, Toth E, Landry M, Drolet JP, Top KA, De Serres G

    Rate of Recurrence of Adverse Events Following Immunization: Results of 19 Years of Surveillance In Quebec, Canada

    Pediatr Infect Dis J 38 (4), 2019.

    DOI PUBMED
  • article Desjardins M, Béland M, Dembele M, Lejtenyi D, Drolet JP, Lemire M, Tsoukas C, Ben-Shoshan M, Noya FJD, Alizadehfar R, McCusker CT, Mazer BD

    Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications

    J Clin Immunol 38 (1), 2018.

    DOI PUBMED
  • article Zafack JG, De Serres G, Rouleau I, Gariepy MC, Gagnon R, Drolet JP, Skowronski DM

    Clinical Approach Used in Medical Consultations for Allergic-Like Events Following Immunization: Case Series Report in Relation to Practice Guidelines

    J Allergy Clin Immunol Pract 5 (3), 2017.

    DOI PUBMED
  • article Viel-Theriault I, Thibeault R, Boucher FD, Drolet JP

    Thalidomide in Refractory Tuberculomas and Pseudoabscesses

    Pediatr Infect Dis J 35 (11), 2016.

    DOI PUBMED
  • article Rouleau I, De Serres G, Skowronski DM, Drolet JP, Lemire C, Toth E, Landry M

    Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada

    Vaccine 32 (28), 2014.

    DOI PUBMED
  • article Rouleau I, De Serres G, Drolet JP, Skowronski D, Ouakki M, Toth E, Landry M, Menard S, Gagnon R

    Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine

    Vaccine 31 (50), 2013.

    DOI PUBMED
  • article Rouleau I, De Serres G, Drolet JP, Banerjee D, Lemire C, Moore A, Paradis L, Alizadhefar R, Des Roches A, Chan ES, Stark D, Benoit M, Skowronski DM and

    Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE

    J Allergy Clin Immunol 130 (6), 2012.

    DOI PUBMED
  • article Drolet JP, Frangie H, Guay J, Hajoui O, Hamid Q, Mazer BD

    B lymphocytes in inflammatory airway diseases

    Clin Exp Allergy 40 (6), 2010.

    DOI PUBMED